ationwide research on management of inherited thrombophilia in pregnancy
Not Applicable
- Conditions
- pregnant women with inherited thormbophilia
- Registration Number
- JPRN-UMIN000037155
- Lead Sponsor
- Hamamatsu Medical Center
- Brief Summary
AT,PC,PS deficiency were observed in 84,67,443 pregnancies,respectively,with incidence rates among total deliveries at 0.012%,0.009%,0.061%. The percentage of institutions that measured both antigens and AT,PC,PS activity for the diagnosis of thrombophilia was 50.2%,46.9% of institutions did not perform gene analysis. Prophylactic anticoagulation therapy was used in the ante- and postpartum management of patients with AT deficiency at 67.1% and 66.3%.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 594
Inclusion Criteria
Not provided
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Matters concerning pregnancy and delivery cases of inherited thrombophilia in the research facilities: 1.The number of five-year deliveries from January 1, 2014 to December 31, 2018. 2. Presence of pregnancy complications of inherited thrombophilia. 3. The number of cases according to type of inherited thrombophilia by year.
- Secondary Outcome Measures
Name Time Method